书目名称 | Cellular Therapies for Retinal Disease | 副标题 | A Strategic Approach | 编辑 | Steven D. Schwartz,Aaron Nagiel,Robert Lanza | 视频video | | 概述 | Drs. Schwartz and Lanza are two of the best known names in stem cell research and Dr. Schwartz is known particularly for clinical trials for stem cell therapies for ophthalmologic diseases.Focuses on | 图书封面 |  | 描述 | This book familiarizes the reader with the current landscape of cell-based therapies for the treatment of retinal disease, including diseases that affect the choriocapillaris, retinal pigment epithelium, photoreceptors, and retinal ganglion cells. Instead of utilizing a disease-centric approach to the topic, this book—edited by two world-renowned stem cell scientists—focuses on strategies for developing and transplanting the cells. This includes the creation of replacement cells, cell-based neuroprotection, and in vitro disease modeling and testing. The final chapters briefly review parallel approaches that do not directly utilize cellular transplantation..The use of cellular transplantation to treat retinal disease has recently become a viable and exciting therapeutic approach. The visibility of the retina and its laminar cellular architecture render it an ideal organ for the development of surgically delivered cellular therapies. Having an in-depth understanding ofthe current state of cell therapy for the eye is an essential first step toward utilizing similar approaches in other organs. Ophthalmologists, translational clinician-scientists, stem cell scientists, and researchers i | 出版日期 | Book 2017 | 关键词 | Cell-based Neuroprotection; Cell Transplantation; Choriocapillaris; Pluripotent Stem Cells; Retinal Pigm | 版次 | 1 | doi | https://doi.org/10.1007/978-3-319-49479-1 | isbn_softcover | 978-3-319-84169-4 | isbn_ebook | 978-3-319-49479-1 | copyright | Springer International Publishing AG 2017 |
The information of publication is updating
|
|